<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04726046</url>
  </required_header>
  <id_info>
    <org_study_id>ChonbukNUH</org_study_id>
    <nct_id>NCT04726046</nct_id>
  </id_info>
  <brief_title>Effectiveness of Prophylactic Antibiotics Therapy in Laparoscopic Cholecystectomy on Infection Rate</brief_title>
  <official_title>Prospective Randomized Control Study of Clinical Effectiveness of Prophylactic Antibiotics Therapy in Laparoscopic Cholecystectomy on Infection Rate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chonbuk National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chonbuk National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      529 patients performed elective LCC at Chonbuk National University Hospital between April&#xD;
      2014 and August 2015. Total 509 patients were enrolled by inclusion criteria.&#xD;
&#xD;
      They were randomized studied by comparing with antibiotic group (n=249, AG, cefotetan 1g, 1&#xD;
      dose/prophylactic) and non-antibiotic group (n=260, NAG) by table of random numbers. The&#xD;
      clinical variables were pre and post-operatively blood tests enclude WBC, ESR, CRP, body&#xD;
      temperatures, symptoms and imaging of chest x-ray to evaluate the infections.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      529 patients performed elective LCC at Chonbuk National University Hospital between April&#xD;
      2014 and August 2015. Total 509 patients were enrolled by inclusion criteria. They were&#xD;
      randomized studied by comparing with antibiotic group (n=249, AG, cefotetan 1g, 1&#xD;
      dose/prophylactic) and non-antibiotic group (n=260, NAG) by table of random numbers. The&#xD;
      clinical variables were pre and post-operatively blood tests enclude WBC, ESR, CRP, body&#xD;
      temperatures, symptoms and imaging of chest x-ray to evaluate the infections.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2014</start_date>
  <completion_date type="Actual">September 25, 2017</completion_date>
  <primary_completion_date type="Actual">August 1, 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>surgical complication</measure>
    <time_frame>30days</time_frame>
    <description>surgical site infection</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">529</enrollment>
  <condition>Cholecystitis</condition>
  <arm_group>
    <arm_group_label>Antibiotic treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>They were Antibiotic treatment group (AG, cefotetan 1g, 1 dose/prophylactic) before surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-antibiotic treatment group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>They were Non-antibiotics treatment such as cefotetan 1g before surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cefotetan</intervention_name>
    <description>Cefotetan (as Disodium) 1 GM Injection before surgery</description>
    <arm_group_label>Antibiotic treatment group</arm_group_label>
    <other_name>antibiotics group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        patients who have diagnosed -cholecystitis with / without GB stone, GB polyp&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Suspected cholangitis and GB cancer&#xD;
&#xD;
          2. CBD stone history&#xD;
&#xD;
          3. Preoperative administration of antibiotics within 7days.&#xD;
&#xD;
          4. Suspected pregnancy&#xD;
&#xD;
          5. Open conversion.&#xD;
&#xD;
          6. Patients refuse this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jae Do Yang</last_name>
    <role>Study Director</role>
    <affiliation>Chonkbuk national university</affiliation>
  </overall_official>
  <verification_date>September 2017</verification_date>
  <study_first_submitted>September 18, 2017</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2021</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GB stone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholecystitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Cefotetan</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

